Anaphylaxis is a life-threatening allergic reaction to environmental substances, which can occur in minutes or seconds. Frequent reactions involve exposure to food, drugs, and insect venom. Indicators of anaphylaxis include skin rashes, swelling/irritation in the mouth, difficulty breathing, nausea and vomiting.



Many patients do not have their epinephrine auto-injector(s) in the emergency of an anaphylactic episode, mainly due to the inconvenient bulk of current epinephrine rescue devices. Large auto-injectors are bothersome to carry on a daily basis, resulting in lack of availability. AllergyStop® alleviates this burden, placing a palm-sized epinephrine device within arms reach on a keychain or belt loop.


Additional lack of auto-injector availability is attributed to inflated costs of epinephrine devices and failure to order and pick-up prescriptions. AllergyStop® provides the solution to each of these issues to ensure easy access to epinephrine at all times.





Planned Custom Features: 


Needle Length

Current devices offer a “one size fits all” needle length for children and adults. Although skin-to-muscle depth is proportionally similar in healthy children and adults, the world has a large percentage of unhealthy individuals. According to the CDC, 34.9% of U.S. adults (78.6 million) and 17% of children (12.7 million) are obese. Obesity, in relevant terms, is the addition of excess subcutaneous adipose tissue (fat) between an individual’s skin and muscle. This condition increases the necessary needle length to achieve intramuscular injection and rapid epinephrine absorption to halt anaphylaxis. 


Medication Dose

AllergyStop plans to be released in 2 doses, a pediatric dose 0.15mg epinephrine as well as adult dose 0.3 mg epinephrine.


Carrying Case 

AllergyStop® comes packaged in a compact carrying case, available in a variety of colors. Custom cases also include an antihistamine compartment to conveniently store medication to counteract less severe reactions. 



AllergyStop® plans to offer patient specific needle lengths and epinephrine doses based on body mass index (BMI), accounting for patient height and weight. Physician submissions are required for custom prescriptions.